Psychoactive Substances

Welcome to a new episode of the Benzinga Psychedelics Podcast where we're joined by Stephanie Wang, founder of business KA! Empathogenics and speaker about alternative mental health, emotional wellness, resilience-building in the nervous system and connection to self, others and nature through the...

Welcome to a new episode of our Benzinga Psychedelics Podcast. We are joined herein by executives of Clearmind Medicine (NASDAQ:CMND), a biotech company developing a proprietary, psychoactive yet non-hallucinogenic treatment for a diverse array of addictive behaviors, with Alcohol Use Disorder (aka...

Enveric Biosciences (NASDAQ:ENVB), a Florida-headquartered biotech company developing novel neuroplasticity-promoting small molecule therapeutics for depression, anxiety and addiction disorders treatment has signed three non-binding term sheets with another (undisclosed) biotechnology company...

Numerous companies in the psychedelics industry are essentially advancing research on compounds that have a history of past use. Some of them are particularly focusing on the believed effects that millenary plants hold and targeting contemporary mental health conditions by performing a scientific...

Canadian drug development company Lucy Scientific Discovery Inc. (NASDAQ: LSDI) is set to acquire e-commerce platform and plant-based wellness brands company BlueSky Wellness Inc. toward further entering the global wellness market with novel psychotropic products.  Last week, Lucy...

A recent study reveals that marijuana users have higher levels of heavy metals in their blood and urine compared to non-users. According to a report published on Wednesday by The Hill, the study was conducted at Columbia University's Mailman School of Public...

In a recent interview with CNN, U.S. Treasury Secretary Janet Yellen casually recognized that she tried magic mushrooms at a dinner during her July official visit to China. Although “delicious,” the mushrooms didn’t make her trip. Yellen added that she was only informed that...

Amanita Muscaria is the only kind of mushroom currently legal. As its health benefits are regularly being confirmed in studies, demand for related products is rapidly growing. This scenario has compelled Colorado-based Panacea Life Sciences (OTCQB: PLSH) to conduct research and...

Biotech company FSD Pharma Inc. (NASDAQ: HUGE)’s Australian business FSD Pharma Australia Pty Ltd. has been approved by the Alfred Ethics Committee to begin a Phase 1 clinical trial of next-gen drug candidate Lucid-201, or Lucid-Psych, for cases of Major Depressive Disorder (MDD.) ...

Psychedelics producer Lucy Scientific Discovery Inc. (NASDAQ: LSDI) is launching a new brand of products containing unscheduled psychoactive compounds, soon available for sale in the U.S. and all other parts of the world where legal. The first of the brand’s product lines, “Mindful by...

Psychedelic therapeutics biotech company PsyBio Therapeutics Corp. (OTCQB: PSYBF) has filed three additional U.S. provisional patent applications covering its latest discoveries on production of synthetic 5-MeO-DMT, AKA “toad venom” in that this psychedelic substance is naturally...

The University of Wisconsin-Madison Transdisciplinary Center for Research in Psychoactive Substances (TCRPS) was created to foster education and research on the field of medical applications of psychedelics, and one of them is specifically studying if remembering the psychedelic-induced...